Loading clinical trials...
Loading clinical trials...
Phase III, Randomized, Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device With Conventional Drug Treatment, Compared to Conventional Drug Treatment Alone, in Adult Patients With Moderate to Severe Generalized Anxiety Disorder
Conditions
Interventions
App AURORA (Digital Therapy) + conventional treatment
Pharmacological conventional treatment
Locations
1
Mexico
Servicios Especializados En Ensayos Clinicos, Seec, Sc
Mexico City, Mexico City, Mexico
Start Date
March 29, 2026
Primary Completion Date
June 29, 2027
Completion Date
July 1, 2027
Last Updated
April 1, 2026
NCT06653296
NCT00411398
Lead Sponsor
Psicofarma, S.A. De C.V.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions